AN2 Therapeutics Inc ANTX

US Pharmaceuticals

$3.97 ▼ -0.75% ($-0.03)

⬇️ Below Yest. Low 📅 Earnings This Week

Open $4.00

Prev Close $4.00

Day Range $3.93 – $4.14

52W Range $1.00 – $7.19

Market Cap $150.94M

Beta -0.93

EPS (TTM) $-1.07

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2022-03-25
Shares Out.	37,740,000
Website	an2therapeutics.com/ ↗
Phone	18004831140
Employees	21
Revenue	$0
Gross Profit	$0
Net Income	-$8.2M
Free Cash Flow	-$30.7M
Total Assets	$81.7M
Total Liabilities	$5.8M
Equity	$75.9M

About AN2 Therapeutics Inc

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

AN2 Therapeutics Inc is a publicly traded company under the ticker symbol ANTX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.